Summary
Background
Few studies of practice variation in the management of early breast cancer for elderly women have examined the process of care in depth. This study evaluated the effects of age and other factors on surgical staging techniques and treatment.
Methods
Virginia cancer registry data were linked with Medicare claims and 1990 census data. The sample included all newly diagnosed patients with pathologic confirmed local and regional breast cancer in 1985–1989 (n=3,361). Analyses included descriptive univariate statistics and multiple logistic regression analysis for staging and treatment alternatives. Process of care variables included tumor size determination, axillary lymph node dissection, use of adjuvant therapy, and radiation if breast conserving surgery (BCS) was performed.
Results
About 75 percent of women had tumor size and axillary node dissection. Increasing comorbidity was associated with a lower likelihood of axillary node dissection. Nine percent of local compared to 44 percent of regional disease patients received adjuvant therapy. Hormonal therapy increased from 13 percent of women in 1985–1988 to 24 percent in 1989. Hormonal therapy did not vary with patient age. One-third of the patients with positive lymph nodes compared to 8 percent of node negative women received hormonal therapy. Blacks were more likely to present with advanced disease. A logistic regression model evaluated the multiple effects of patients and clinical characteristics: older women were more likely to present with larger tumors, were less likely to have axillary node dissections, and were less likely to receive chemotherapy or radiation.
Conclusions
Younger age was most consistently associated with staging and the use of chemotherapy in this cohort of elderly breast cancer patients. Based on the reported initial treatment plan, hormonal therapy was infrequently used and information from axillary lymph node assessment was used to stratify treatment. Although the low use of adjuvant hormonal therapy in elderly women may compromise survival, neither comorbid nor socioeconomic factors as measured in this study explained this practice pattern.
This is a preview of subscription content, log in via an institution to check access.
References
Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS: Geographic variation in the use of breast-conserving treatment for breast cancer [see comments]. N Engl J Med 326:1102–1107, 1992
Farrow DC, Hunt WC, Samet JM: Geographic variation in the treatment of localized breast cancer [see comments]. N Engl J Med 326:1097–1101, 1992
Hand R, Sener S, Imperato J, Chmiel JS, Sylvester JA, Fremgen A: Hospital variables associated with quality of care for breast cancer patients [see comments]. JAMA 266:3429–3432, 1991
Hynes DM: The quality of breast cancer care in local communities: Implications for health care reform. Med Care 32:328–340, 1994
Desch CE, Penberthy L, Newschaffer CJ, et al: Factors that determine the treatment for local and regional prostate cancer. Med Care (in press)
Newschaffer CJ, Penberthy L, Desch CE, Retchin SM: Co-morbidity and age-related treatment patterns for non-metastatic breast cancer in elderly women. Arch Intern Med (in press)
Silverberg E, Boring CC, Squires TS: Cancer statistics, 1990. CA-A Cancer Journal 40:9–26, 1990
Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383, 1987
Malenka DJ, McLerran D, Roos N, Fisher ES, Wennberg JE: Using administrative data to describe case mix: a comparison with the medical record. J Clin Epidemiol 47:1027–1032, 1994
Consensus Conference: Adjuvant chemotherapy for breast cancer. JAMA 254:3461–3463, 1985
NIH Consensus Conference: Treatment of early-stage breast cancer. JAMA 265:391–395, 1991
Kassirer JP: The quality of care and quality of measuring it. N Engl J Med 329:1263–1265, 1993
Osteen RT: Breast Cancer.In: Steele GD, Winchester DP, Menck HR, Murphy GP (eds): National Cancer Data Base, 1992. American Cancer Society, Atlanta, 1992, pp 29–38
Johnson TP, Ford L, Warnecke RB, et al: Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns. J Clin Oncol 12:1783–1788, 1994
Eley JW, Hill HA, Chen VW, et al: Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272:947–954, 1994
Early Breast Cancer Trialists' Collaborative Group: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women. N Engl J Med 319:1681–1692, 1988
National Cancer Institute: Clinical Alert. National Cancer Institute, Bethesda MD, May 16–18, 1988
Harris JR, Morrow M, Bonadonna G: Cancer of the breast.In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology. Lippincott, Philadelphia, 1994, pp 1264–1332
Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339:1–15,71–85, 1992
Castiglione M, Gelber RD, Goldhirsch A: Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group. J Clin Oncol 8:519–526, 1990
Cummings FJ, Gray R, Tormey DC, et al: Adjuvant tamoxifen versus placebo in elderly women with nodepositive breast cancer: long-term follow-up and causes of death [see comments]. J Clin Oncol 11:29–35, 1993
Harris JR, Lippman ME, Veronesi U, Willett W: Breast cancer (2). N Engl J Med 327:390–398, 1992
Fisher B, Redmond C, Fisher ER, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674–681, 1985
Kantorowitz DA, Poulter CA, Sischy B, et al: Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus postoperative radiotherapy. Int J Radiation Oncology Biol Phys 15:263–270, 1988
Veronesi U, Luini A, Del Vecchio M, et al: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast [see comments]. N Engl J Med 328:1587–1591, 1993
Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB: Discordance of databases designed for claims payment versus clinical information systems. Ann Intern Med 119:844–850, 1993
Roos LL, Sharp SM, Cohen MM: Comparing clinical information with claims data: some similarities and differences [see comments]. J Clin Epidemiol 44:881–888, 1991
Greenfield S, Blanco DM, Elashoff RM, Ganz PA: Patterns of care related to age of breast cancer patients. JAMA 257:2766–2770, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hillner, B.E., Penberthy, L., Desch, C.E. et al. Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Tr 40, 75–86 (1996). https://doi.org/10.1007/BF01806004
Issue Date:
DOI: https://doi.org/10.1007/BF01806004